Clinical study investigating background factors that affect the prognosis of patients with relapsed or metastatic renal cell carcinoma
Not Applicable
- Conditions
- renal cell carcinoma
- Registration Number
- JPRN-UMIN000043415
- Lead Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Brief Summary
A comprehensive analysis of baseline characteristics related to OS after initiation of first-line TKI therapy in patients with advanced metastatic RCC was executed. This analysis suggested that gender, age, ECOGPS, presence of liver or bone metastases, CRP, WHO/ISUP grade, LDH, and albumin were factors associated with prognosis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 770
Inclusion Criteria
Not provided
Exclusion Criteria
Not applicable Refer from ARCHERY study (UMIN000034131) exclusion criteria.
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method OS defined as the time from initiation of first-line treatment to death.
- Secondary Outcome Measures
Name Time Method Duration of first-line treatment. OS by factor of interest. Duration of first-line treatment by factor of interest. Reasons for discontinuing first-line and second-line treatment by age.